Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

DHEA boosts bone cell growth and differentiation in elderly stem cells.

Adult female acne is complex and requires a combination of treatments for effective management.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Invasive treatments can improve hair growth, but effectiveness varies and more research is needed.

Understanding hair follicle signaling can improve hair disorder treatments.

Mechanical stimulation and new therapies show promise for hair regrowth.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Fire Needle Therapy may help bring back skin color in vitiligo by affecting cell growth signals.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Vitiligo treatments are improving but still face challenges and high relapse rates.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.

New therapies like JAK inhibitors and stem cells show promise for treating vitiligo.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.